Holen Sie sich die Stockscreener-App
1.85
3.65%
-0.07
Vorhandelsmarkt:
1.90
0.05
+2.70%
Schlusskurs vom Vortag:
$1.92
Offen:
$1.95
24-Stunden-Volumen:
863.81K
Relative Volume:
0.74
Marktkapitalisierung:
$157.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-59.69M
KGV:
-1.3309
EPS:
-1.39
Netto-Cashflow:
$-46.54M
1W Leistung:
-3.14%
1M Leistung:
-12.32%
6M Leistung:
+41.22%
1J Leistung:
+28.47%
1-Tages-Spanne:
$1.85
$1.9574
1-Wochen-Bereich:
$1.76
$1.9574
52-Wochen-Spanne:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Firmenname
Milestone Pharmaceuticals Inc
Sektor
Branche
Telefon
(514) 336-0444
Adresse
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Vergleichen Sie MIST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.85 | 163.19M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-06-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-29 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-07-24 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-25 | Herabstufung | Jefferies | Buy → Hold |
| 2020-03-24 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-03-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-03 | Eingeleitet | Cowen | Outperform |
| 2019-06-03 | Eingeleitet | Jefferies | Buy |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten
How Milestone Pharmaceuticals Inc. stock reacts to oil pricesWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to forecast Milestone Pharmaceuticals Inc. trends using time seriesFed Meeting & High Return Stock Watch Alerts - newser.com
How to interpret RSI for Milestone Pharmaceuticals Inc. stockJuly 2025 Earnings & Safe Swing Trade Setups - newser.com
Can Milestone Pharmaceuticals Inc. stock resist sector downturnsEarnings Performance Report & Verified Short-Term Plans - newser.com
Advanced analytics toolkit walkthrough for Milestone Pharmaceuticals Inc.Quarterly Risk Review & Smart Money Movement Alerts - newser.com
Milestone Pharmaceuticals (MIST) Highlights Promising Results fo - GuruFocus
Using Bollinger Bands to evaluate Milestone Pharmaceuticals Inc.Take Profit & Risk Adjusted Buy and Sell Alerts - newser.com
Milestone Pharmaceuticals Reports Positive Efficacy and Safety Data for Etripamil Nasal Spray in Management of Paroxysmal Supraventricular Tachycardia - Quiver Quantitative
Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025 - Stock Titan
Combining price and volume data for Milestone Pharmaceuticals Inc.Inflation Watch & Weekly Stock Performance Updates - newser.com
Will Milestone Pharmaceuticals Inc. stock remain a Wall Street favoriteRate Cut & Fast Gain Swing Trade Alerts - newser.com
What Fibonacci levels say about Milestone Pharmaceuticals Inc. reboundTrade Exit Summary & Verified Entry Point Signals - newser.com
Is Milestone Pharmaceuticals Inc. stock bottoming outMarket Risk Summary & Community Consensus Picks - newser.com
Can Milestone Pharmaceuticals Inc. recover in the next quarterEarnings Recap Summary & Community Supported Trade Ideas - newser.com
How Milestone Pharmaceuticals Inc. stock performs during Fed tightening cyclesEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Real time social sentiment graph for Milestone Pharmaceuticals Inc.Portfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright - MSN
What momentum shifts mean for Milestone Pharmaceuticals Inc.Weekly Trade Analysis & Reliable Entry Point Alerts - newser.com
What the charts say about Milestone Pharmaceuticals Inc. today2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Is it too late to sell Milestone Pharmaceuticals Inc.July 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Can Milestone Pharmaceuticals Inc. stock maintain operating marginsPortfolio Value Summary & Daily Stock Trend Watchlist - newser.com
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Rating of "Hold" by Brokerages - MarketBeat
Detecting support and resistance levels for Milestone Pharmaceuticals Inc.Oil Prices & Fast Exit/Entry Strategy Plans - newser.com
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):